Related Experiment Video
Updated: May 22, 2025

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
Published on: March 26, 2018
Aortic Valve Replacement in the Current Era
Shannon Parness1, Jack T Womble1, Tori E Hester1
1Division of Cardiothoracic Surgery, Department of Surgery, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Insights
Aortic valve replacement (AVR) treats severe aortic valve disease (AVD). New techniques like TAVR expand treatment options, improving outcomes for more patients with AVD.
Area of Science:
- Cardiovascular Surgery
- Valvular Heart Disease
- Medical Technology
Background:
- Aortic valve disease (AVD) is a widespread global health issue.
- Aortic valve replacement (AVR) is the primary surgical intervention for severe AVD.
- AVD stems from various causes, including aortic stenosis, aortic insufficiency, endocarditis, and congenital defects.
Purpose of the Study:
- To review the current landscape of aortic valve replacement (AVR) for aortic valve disease (AVD).
- To highlight advancements in surgical techniques and their impact on patient candidacy.
- To emphasize the importance of personalized treatment strategies in AVR.
Main Methods:
- Review of current literature on AVD and AVR.
- Analysis of novel surgical techniques such as transcatheter AVR (TAVR) and sutureless valves.
- Discussion of factors influencing AVR decision-making, including patient age and VKA compatibility.
Main Results:
- AVR remains a cornerstone treatment for severe AVD.
- Innovative techniques like TAVR and sutureless valves have broadened access to AVR.
- Shared decision-making is crucial for selecting appropriate valve types and surgical approaches.
Conclusions:
- Continued research is vital for enhancing patient outcomes and expanding AVR eligibility.
- AVR is expected to maintain its significant role in managing AVD.
- Personalized patient care, considering age and VKA compatibility, is key to successful AVR outcomes.
Abstract:
Aortic valve disease (AVD) is a highly prevalent condition worldwide. Aortic valve replacement (AVR) is the surgical treatment for those with severe disease. Common etiologies of AVD include aortic stenosis (AS), aortic insufficiency (AI), endocarditis, and congenital diseases. Shared decision-making plays a large role in the treatment methodology chosen for each patient. Selection of valve type and surgical intervention requires strong considerations of age and compatibility with vitamin K antagonists (VKAs) to ensure optimal post-operative outcomes. Due to the development of novel surgical techniques, including transcatheter AVR (TAVR) and placement of sutureless valves, patients who previously had limited access to AVD surgical options can now be considered for AVR. Further research into therapeutic development is imperative to improve patient short- and long-term outcomes as well as widen surgical candidacy for those seeking AVR for the management of AVD. Overall, AVR will continue to hold its prominent role in the treatment of AVD.
More Related Videos
05:31Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
Published on: June 8, 2022
12:17Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
Published on: May 21, 2017